Articles

A new USC Schaeffer Center white paper shows how state-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.

Congress can expand healthcare to millions of Americans by enrolling individuals in the 12 states that did not expand Medicaid.

The proposed reforms are a helpful start, but could go further in addressing the lack of competition in the U.S. PBM market.

Anti-competitive practices and a lack of transparency in the generic drug market allow pharmacy benefit managers to profit off patients and payers.

Analysis of cases that went through dispute resolution found the final allowed were largely anchored to the established.

Child care providers, many already struggling before COVID, have been hit hard over the past two years. Plummeting demand for child care, increased cleaning and supply costs, virus safety measures and capacity restrictions created a perfect storm of stressors, said providers and experts familiar with the child care field.

To reduce hospitalization and death, pharmacists should have the same prescribing abilities as doctors for COVID anti-viral drugs Paxlovid and Lagevrio, USC School of Pharmacy
Dean Vassilios Papadopoulos writes in a new MarketWatch op-ed.

USC has received $5.8 million from Gates Ventures and the American Heart Association to launch a lab aimed at diversifying clinical trials.

A new USC Schaeffer Center paper highlights tactics used by intermediaries in the pharmaceutical distribution system, including pharmacy benefit managers (PBMs) and insurers, that are costing patients, employers and the government billions for what should be inexpensive medicines.

Researchers observed a 23% drop in opioid prescriptions and a 27% increase in prescriptions for naloxone.